Home / Private raises / Pathos AI, Inc.
Pathos AI, Inc.
Biotechnology · Chicago, Illinois · $238M sold across 1 offering
Form D filings (1)
| Filed | Form | Sold | Offered | Investors | Exemption | Securities | First sale | |
|---|---|---|---|---|---|---|---|---|
| 2026-11-19 | D (new) | $238M | $300M | 13 | 506(c) | Equity | Aug 21 | SEC ↗ |
An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.
Issuer
| Industry | Biotechnology |
| Located | Chicago, Illinois |
| Entity | Corporation |
| Incorporated | Delaware |
| SEC CIK | 1967854 |
People named in the latest filing
| Name | Role |
|---|---|
| Iker Huerga | Executive Officer, Director |
| Alex Dolan | Executive Officer |
| Eric Lefkofsky | Director |
| Ryan Fukushima | Director |
| Mohamad Makhzoumi | Director |
| Tyrell Rivers | Director |
| Mike Mauceri | Executive Officer |
Names and roles as filed with the SEC. Addresses are not shown.
Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.
How are we doing?
